Results 141 to 150 of about 1,463,301 (359)
With newer tools for gene editing, is it time to revisit genetic therapy for cystic fibrosis? [PDF]
Gupta A, Gupta A, Boyd L.
europepmc +1 more source
Genetically targeted research & therapeutics: Antisense & gene therapy [PDF]
openalex +1 more source
The authors applied joint/mixed models that predict mortality of trifluridine/tipiracil‐treated metastatic colorectal cancer patients based on circulating tumor DNA (ctDNA) trajectories. Patients at high risk of death could be spared aggressive therapy with the prospect of a higher quality of life in their remaining lifetime, whereas patients with a ...
Matthias Unseld+7 more
wiley +1 more source
Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I. [PDF]
Belur LR+13 more
europepmc +1 more source
Genetic Therapy for Breast Cancer Reaches the Drawing Board [PDF]
G. McBride
openalex +1 more source
Breast tumor samples scored for metabolic deregulation (M1 to M3) were given a hypoxia score (HS). The highest HS occurred in patients with strongest metabolic deregulation (M3), supporting tumor aggressiveness. HS correlated with the highest number of metabolic pathways in M1. This suggests hypoxia to be an early event in metabolic deregulation.
Raefa Abou Khouzam+2 more
wiley +1 more source
KRONİK AĞRIDA GENETİK TEDAVİ VE HEMŞİRENİN ROLÜ
Kronik ağrı, insidansı yüksek olan önemli sağlık sorunlarından biridir. Kronik ağrı bireyin yaşam kalitesini olumsuz etkilemekte, immun sistemi baskılama, anksiyete, depresyon ve intihara eğilim gibi ciddi komplikasyonlara yol açmaktadır.
Kübra Yılmaz, Sema Koçaşlı
doaj
Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies [PDF]
Patrice S. Obermiller+2 more
openalex +1 more source
Mapping genetic interactions in cancer: a road to rational combination therapies. [PDF]
The discovery of synthetic lethal interactions between poly (ADP-ribose) polymerase (PARP) inhibitors and BRCA genes, which are involved in homologous recombination, led to the approval of PARP inhibition as a monotherapy for patients with BRCA1/2 ...
Krogan, Nevan J, Tutuncuoglu, Beril
core
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou+13 more
wiley +1 more source